Inactivation of endothelial ZEB1 impedes tumor progression and sensitizes tumors to conventional therapies

R Fu, Y Li, N Jiang, BX Ren, CZ Zang… - The Journal of …, 2020 - Am Soc Clin Investig
Current antiangiogenic therapy is limited by its cytostatic property, scarce drug delivery to
the tumor, and side toxicity. To address these limitations, we unveiled the role of ZEB1, a …

ZEB1 drives epithelial-to-mesenchymal transition in lung cancer

JE Larsen, V Nathan, JK Osborne… - The Journal of …, 2016 - Am Soc Clin Investig
Increased expression of zinc finger E-box binding homeobox 1 (ZEB1) is associated with
tumor grade and metastasis in lung cancer, likely due to its role as a transcription factor in …

[HTML][HTML] ZEB2 promotes tumor metastasis and correlates with poor prognosis of human colorectal cancer

MZ Li, JJ Wang, SB Yang, WF Li, LB Xiao… - American journal of …, 2017 - ncbi.nlm.nih.gov
Colorectal cancer remains the most common cause of cancer-related deaths worldwide and
it continues to lack an effective treatment. Here, we found that zinc finger E-box binding …

Regulation of ZEB1 function and molecular associations in tumor progression and metastasis

M Perez-Oquendo, DL Gibbons - Cancers, 2022 - mdpi.com
Simple Summary Given the importance of the epithelial-to-mesenchymal transition in tumor
progression and the pivotal role of ZEB1 as a transcriptional repressor during this process …

ZEB1 upregulates VEGF expression and stimulates angiogenesis in breast cancer

L Liu, Q Tong, S Liu, J Cui, Q Zhang, W Sun, S Yang - PLoS One, 2016 - journals.plos.org
Although zinc finger E-box binding homeobox 1 (ZEB1) has been identified as a key factor in
the regulation of breast cancer differentiation and metastasis, its potential role in modulating …

[HTML][HTML] ZEB1 transcription factor promotes immune escape in melanoma

M Plaschka, V Benboubker, M Grimont… - … for Immunotherapy of …, 2022 - ncbi.nlm.nih.gov
Background The efficacy of immunotherapies in metastatic melanoma depends on a robust
T cell infiltration. Oncogenic alterations of tumor cells have been associated to T cell …

[HTML][HTML] ZEB1: catalyst of immune escape during tumor metastasis

J Lu, F Fei, C Wu, J Mei, J Xu, P Lu - Biomedicine & Pharmacotherapy, 2022 - Elsevier
The transcription factor zinc finger E-box binding homeobox 1 (ZEB1) is a critical inducer of
epithelial mesenchymal transformation (EMT) and plays a robust role in tumor metastasis. It …

EphrinB2 repression through ZEB2 mediates tumour invasion and anti-angiogenic resistance

C Depner, H Zum Buttel, N Böğürcü, AM Cuesta… - Nature …, 2016 - nature.com
Diffuse invasion of the surrounding brain parenchyma is a major obstacle in the treatment of
gliomas with various therapeutics, including anti-angiogenic agents. Here we identify the epi …

[HTML][HTML] The roles of ZEB1 in tumorigenic progression and epigenetic modifications

Y Zhang, L Xu, A Li, X Han - Biomedicine & Pharmacotherapy, 2019 - Elsevier
Highly expressed Zinc-finger E-box binding protein 1 (ZEB1) is significantly associated with
the malignancy of various cancers. Signal transduction and activation of ZEB1 play …

Genome-wide analysis of endogenously expressed ZEB2 binding sites reveals inverse correlations between ZEB2 and GalNAc-transferase GALNT3 in human tumors

P Balcik-Ercin, M Cetin, I Yalim-Camci, G Odabas… - Cellular Oncology, 2018 - Springer
Background ZEB2 is a transcriptional repressor that regulates epithelial-to-mesenchymal
transition (EMT) through binding to bipartite E-box motifs in gene regulatory regions. Despite …